<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-5691</journal-id>
<journal-title><![CDATA[Mundo nano. Revista interdisciplinaria en nanociencias y nanotecnología]]></journal-title>
<abbrev-journal-title><![CDATA[Mundo nano]]></abbrev-journal-title>
<issn>2448-5691</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional Autónoma de México, Instituto de Ciencias Aplicadas y Tecnología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-56912022000100401</article-id>
<article-id pub-id-type="doi">10.22201/ceiich.24485691e.2022.28.69682</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Gobernanza de la nanomedicina: una revisión sistemática]]></article-title>
<article-title xml:lang="en"><![CDATA[Nanomedicine governance: a systematic review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Soto-Vazquez]]></surname>
<given-names><![CDATA[Roberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Záyago Lau]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Maldonado López]]></surname>
<given-names><![CDATA[Luis Alfonso]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Politécnico Nacional Centro de Investigación y de Estudios Avanzados ]]></institution>
<addr-line><![CDATA[Zacatenco ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma de Zacatecas Unidad Académica en Estudios del Desarrollo ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Politécnico Nacional Centro de Investigación y de Estudios Avanzados ]]></institution>
<addr-line><![CDATA[Mérida ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<volume>15</volume>
<numero>28</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-56912022000100401&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-56912022000100401&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-56912022000100401&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La nanomedicina (la aplicación de la nanotecnología en medicina) está revolucionando el diagnóstico, tratamiento y control de enfermedades. Aunque es cierto que esta ha generado importantes beneficios desde el punto de vista médico, existen riesgos toxicológicos, ambientales, éticos y sociales que deben ser analizados. La gobernanza, entre otras cosas, abarca la gestión de riesgos y beneficios de las nuevas tecnologías, por lo que puede aplicarse en nanomedicina para el análisis de riesgos. El objetivo de este artículo es mostrar un panorama de la gobernanza de la nanomedicina a través de una revisión sistemática de la literatura científica. La metodología empleada consistió en los siguientes pasos: 1) búsqueda de artículos en las bases de datos de Scopus, Web of Science y SciELO; 2) limpieza de resultados; 3) obtención de datos altmétricos de la plataforma Dimensions; 4) descarga y lectura de los artículos, y, 5) análisis crítico de los artículos. Como resultado se identificaron deficiencias regulatorias y preocupaciones éticas vinculadas con los productos nanomédicos, pero también se encontraron propuestas para evaluar riesgos y abordar aspectos éticos. Se concluye que, aunque ha habido progresos en la evaluación de riesgos, aún existen asuntos pendientes en materia de regulación.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Nanomedicine bears essential benefits from both medical and technical perspectives. However, there are toxicological, environmental, ethical, and social implications worth researching. Governance encompasses, among other things, the management of risks and benefits of new technologies to minimize risk and, presumably, increasing benefits. This paper aims to show an overview of nanomedicine governance through a systematic review of scientific literature. The methodology consisted of five steps: 1) searching for papers in Scopus, Web of Science and SciELO; 2) cleaning results; 3) gathering altmetrics from Dimensions; 4) reviewing papers, and, 5) critical analysis of the papers. We identified certain regulatory deficiencies and ethical issues related to nanomedical products. There has been an advance in researching threats to health and the environment from nanomedical applications, but there are still gaps in regulation.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[nanomedicina]]></kwd>
<kwd lng="es"><![CDATA[gobernanza]]></kwd>
<kwd lng="es"><![CDATA[regulación]]></kwd>
<kwd lng="es"><![CDATA[riesgos]]></kwd>
<kwd lng="es"><![CDATA[aspectos éticos]]></kwd>
<kwd lng="en"><![CDATA[nanomedicine]]></kwd>
<kwd lng="en"><![CDATA[governance]]></kwd>
<kwd lng="en"><![CDATA[regulation]]></kwd>
<kwd lng="en"><![CDATA[risks]]></kwd>
<kwd lng="en"><![CDATA[ethical issues]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Altenstetter]]></surname>
<given-names><![CDATA[Christa]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical device regulation and nanotechnologies: determining the role of patient safety concerns in policymaking]]></article-title>
<source><![CDATA[Law &amp; Policy]]></source>
<year>2011</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>227-55</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez-Díaz]]></surname>
<given-names><![CDATA[Jorge Alberto]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retos de la bioética en la medicina del siglo XXI]]></article-title>
<source><![CDATA[Revista Peruana de Medicina Experimental y Salud Publica]]></source>
<year>2011</year>
<volume>28</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>657-63</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anand]]></surname>
<given-names><![CDATA[Manish]]></given-names>
</name>
<name>
<surname><![CDATA[Srivastava]]></surname>
<given-names><![CDATA[Nidhi]]></given-names>
</name>
<name>
<surname><![CDATA[Sarma]]></surname>
<given-names><![CDATA[Shilpanjali]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Policy and ethical concerns in nanotechnology safety: case of Indian Health Sector]]></article-title>
<source><![CDATA[Journal of Biomedical Nanotechnology]]></source>
<year>2011</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-5</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andorno]]></surname>
<given-names><![CDATA[Roberto]]></given-names>
</name>
<name>
<surname><![CDATA[Biller-Andorno]]></surname>
<given-names><![CDATA[Nikola]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The risks of nanomedicine and the precautionary principle]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Gordijn]]></surname>
<given-names><![CDATA[Bert]]></given-names>
</name>
<name>
<surname><![CDATA[Cutter]]></surname>
<given-names><![CDATA[Anthony Mark]]></given-names>
</name>
</person-group>
<source><![CDATA[In pursuit of nanoethics]]></source>
<year>2014</year>
<page-range>131-45</page-range><publisher-loc><![CDATA[Dordrecht ]]></publisher-loc>
<publisher-name><![CDATA[The International Library of Ethics, Law and Technology]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anzaldo]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<name>
<surname><![CDATA[Chauvet]]></surname>
<given-names><![CDATA[Michelle]]></given-names>
</name>
<name>
<surname><![CDATA[Maldonado]]></surname>
<given-names><![CDATA[Luis A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fondos públicos para la investigación en nanotecnologías en México y el cambio de paradigma de la política de CTI]]></article-title>
<source><![CDATA[Interciencia]]></source>
<year>2014</year>
<volume>39</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-15</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basova]]></surname>
<given-names><![CDATA[Tamara V.]]></given-names>
</name>
<name>
<surname><![CDATA[Vikulova]]></surname>
<given-names><![CDATA[Evgeniia S.]]></given-names>
</name>
<name>
<surname><![CDATA[Dorovskikh]]></surname>
<given-names><![CDATA[Svetlana I.]]></given-names>
</name>
<name>
<surname><![CDATA[Hassan]]></surname>
<given-names><![CDATA[Aseel]]></given-names>
</name>
<name>
<surname><![CDATA[Morozova]]></surname>
<given-names><![CDATA[Natalya B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of noble metal coatings and nanoparticles for the modification of medical implant materials]]></article-title>
<source><![CDATA[Materials &amp; Design]]></source>
<year>2021</year>
<volume>204</volume>
<page-range>109672</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bawa]]></surname>
<given-names><![CDATA[Raj]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[FDA and nano: baby steps, regulatory uncertainty and the bumpy road ahead]]></article-title>
<source><![CDATA[Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Nueva York ]]></publisher-loc>
<publisher-name><![CDATA[Taylor &amp; Francis]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bawa]]></surname>
<given-names><![CDATA[Raj]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[Summer]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Emerging issues in nanomedicine and ethics]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Allhoff]]></surname>
<given-names><![CDATA[Fritz]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[Patrick]]></given-names>
</name>
</person-group>
<source><![CDATA[Nanotechnology &amp; society: Current and emerging ethical issues]]></source>
<year>2009</year>
<page-range>207-23</page-range><publisher-loc><![CDATA[Dordrecht ]]></publisher-loc>
<publisher-name><![CDATA[Springer Netherlands]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bawa]]></surname>
<given-names><![CDATA[Raj]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[Summer]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Overview of ethical issues in nanomedicine]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Mousa]]></surname>
<given-names><![CDATA[Bawa]]></given-names>
</name>
<name>
<surname><![CDATA[Audette]]></surname>
</name>
</person-group>
<source><![CDATA[The road from nanomedicine to precision]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[Mauricio]]></given-names>
</name>
<name>
<surname><![CDATA[Berger Filho]]></surname>
<given-names><![CDATA[Airton Guilherme]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nano-governance, nanoregulación y, ¿nano-ciudadanía?]]></article-title>
<source><![CDATA[Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología]]></source>
<year>2022</year>
<volume>15</volume>
<numero>28</numero>
<issue>28</issue>
<page-range>1e-26e</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bhatia]]></surname>
<given-names><![CDATA[Pooja]]></given-names>
</name>
<name>
<surname><![CDATA[Chugh]]></surname>
<given-names><![CDATA[Archana]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A multilevel governance framework for regulation of nanomedicine in India]]></article-title>
<source><![CDATA[Nanotechnology Reviews]]></source>
<year>2017</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>373-82</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cancino]]></surname>
<given-names><![CDATA[Juliana]]></given-names>
</name>
<name>
<surname><![CDATA[Marangoni]]></surname>
<given-names><![CDATA[Valéria S.]]></given-names>
</name>
<name>
<surname><![CDATA[Zucolotto]]></surname>
<given-names><![CDATA[Valtencir]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotecnologia em medicina: aspectos fundamentais e principais preocupações]]></article-title>
<source><![CDATA[Química Nova]]></source>
<year>2014</year>
<volume>37</volume>
<page-range>521-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caracciolo]]></surname>
<given-names><![CDATA[Giulio]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines]]></article-title>
<source><![CDATA[Nano-medicine: Nanotechnology, Biology and Medicine]]></source>
<year>2015</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>543-57</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Schluesener]]></surname>
<given-names><![CDATA[H. J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanosilver: a nanoproduct in medical application]]></article-title>
<source><![CDATA[Toxicology Letters]]></source>
<year>2008</year>
<volume>176</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-12</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chowdhury]]></surname>
<given-names><![CDATA[Nupur]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Regulation of nanomedicines in the EU: distilling lessons from the pediatric and the advanced therapy medicinal products approaches]]></article-title>
<source><![CDATA[Nanomedicine]]></source>
<year>2010</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>135-42</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cózar Escalante]]></surname>
<given-names><![CDATA[José Manuel de]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dimensiones de la investigación social sobre la nanobiotecnología]]></article-title>
<source><![CDATA[Revista Iberoamericana de Ciencia, Tecnología y Sociedad - CTS]]></source>
<year>2012</year>
<volume>7</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>1-17</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crommelin]]></surname>
<given-names><![CDATA[Daan J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoogevest]]></surname>
<given-names><![CDATA[Peter van]]></given-names>
</name>
<name>
<surname><![CDATA[Storm]]></surname>
<given-names><![CDATA[Gert]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of liposomes in clinical nanomedicine development. What now? Now what?]]></article-title>
<source><![CDATA[Journal of Controlled Release]]></source>
<year>2020</year>
<volume>318</volume>
<page-range>256-63</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Ville]]></surname>
<given-names><![CDATA[Kenneth A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Law, regulation and the medical use of nanotechnology]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Jotterand]]></surname>
<given-names><![CDATA[Fabrice]]></given-names>
</name>
</person-group>
<source><![CDATA[Emerging conceptual, ethical and policy issues in bionanotechnology]]></source>
<year>2008</year>
<page-range>181-200</page-range><publisher-loc><![CDATA[Dordrecht ]]></publisher-loc>
<publisher-name><![CDATA[Springer Netherlands]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado Ramos]]></surname>
<given-names><![CDATA[Gian Carlo]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Burciaga]]></surname>
<given-names><![CDATA[Luis Alberto]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Avances e implicaciones éticosociales de la nanomedicina: una revisión desde el caso del cáncer cerebral]]></article-title>
<source><![CDATA[Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología]]></source>
<year>2013</year>
<volume>6</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>63-85</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dorbeck-Jung]]></surname>
<given-names><![CDATA[Brbel R.]]></given-names>
</name>
<name>
<surname><![CDATA[Chowdhury]]></surname>
<given-names><![CDATA[Nupur]]></given-names>
</name>
</person-group>
<source><![CDATA[Is the European medical products authorisation regulation equipped to cope with the challenges of nanomedicines?]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Rochester, NY ]]></publisher-loc>
<publisher-name><![CDATA[Social Science Research Network]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duncan]]></surname>
<given-names><![CDATA[Ruth]]></given-names>
</name>
<name>
<surname><![CDATA[Gaspar]]></surname>
<given-names><![CDATA[Rogerio]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicine(s) under the microscope]]></article-title>
<source><![CDATA[Molecular Pharmaceutics]]></source>
<year>2011</year>
<volume>8</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2101-41</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[D&#8217;Silva]]></surname>
<given-names><![CDATA[Joel]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[Douglas K. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Shelley-Egan]]></surname>
<given-names><![CDATA[Clare]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A game with rules in the making - how the high probability of waiting games in nanomedicine is being mitigated through distributed regulation and responsible innovation]]></article-title>
<source><![CDATA[Technology Analysis &amp; Strategic Management]]></source>
<year>2012</year>
<volume>24</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>583-602</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="">
<collab>EGE</collab>
<source><![CDATA[Opinion on the ethical aspects of nanomedicine - Opinion N° 21]]></source>
<year>2007</year>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="">
<collab>EU NanoSafety Cluster</collab>
<source><![CDATA[NanoSafety Cluster]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[Robert]]></given-names>
</name>
<name>
<surname><![CDATA[McNamee]]></surname>
<given-names><![CDATA[Michael]]></given-names>
</name>
<name>
<surname><![CDATA[Guy]]></surname>
<given-names><![CDATA[Owen]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethics, nanobiosensors and elite sport: the need for a new governance framework]]></article-title>
<source><![CDATA[Science and Engineering Ethics]]></source>
<year>2017</year>
<volume>23</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1487-505</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="">
<collab>FDA</collab>
<source><![CDATA[Nanotechnology-Over a decade of progress and innovation]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[Guillermo]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La gobernanza de las nanotecnologías]]></article-title>
<source><![CDATA[Sociológica (México)]]></source>
<year>2009</year>
<volume>24</volume>
<numero>71</numero>
<issue>71</issue>
<page-range>125-53</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Funari]]></surname>
<given-names><![CDATA[Riccardo]]></given-names>
</name>
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[Kang-Yu]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[Amy Q.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detection of antibodies against SARS-CoV-2 spike protein by gold nanospikes in an opto-microfluidic chip]]></article-title>
<source><![CDATA[Biosensors and Bioelectronics]]></source>
<year>2020</year>
<volume>169</volume>
<page-range>112578</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gadekar]]></surname>
<given-names><![CDATA[Vedant]]></given-names>
</name>
<name>
<surname><![CDATA[Borade]]></surname>
<given-names><![CDATA[Yogeshwari]]></given-names>
</name>
<name>
<surname><![CDATA[Kannaujia]]></surname>
<given-names><![CDATA[Suraj]]></given-names>
</name>
<name>
<surname><![CDATA[Rajpoot]]></surname>
<given-names><![CDATA[Kuldeep]]></given-names>
</name>
<name>
<surname><![CDATA[Anup]]></surname>
<given-names><![CDATA[Neelima]]></given-names>
</name>
<name>
<surname><![CDATA[Tambe]]></surname>
<given-names><![CDATA[Vishakha]]></given-names>
</name>
<name>
<surname><![CDATA[Kalia]]></surname>
<given-names><![CDATA[Kiran]]></given-names>
</name>
<name>
<surname><![CDATA[Tekade]]></surname>
<given-names><![CDATA[Rakesh K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicines accessible in the market for clinical interventions]]></article-title>
<source><![CDATA[Journal of Controlled Release]]></source>
<year>2021</year>
<volume>330</volume>
<page-range>372-97</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ganau]]></surname>
<given-names><![CDATA[Mario]]></given-names>
</name>
<name>
<surname><![CDATA[Prisco]]></surname>
<given-names><![CDATA[Lara]]></given-names>
</name>
<name>
<surname><![CDATA[Syrmos]]></surname>
<given-names><![CDATA[Nikolaos]]></given-names>
</name>
<name>
<surname><![CDATA[Ganau]]></surname>
<given-names><![CDATA[Laura]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Principles of nanoethics: theoretical models and clinical practice]]></article-title>
<source><![CDATA[Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Nueva York ]]></publisher-loc>
<publisher-name><![CDATA[Taylor &amp; Francis]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carelli]]></surname>
<given-names><![CDATA[Giroto]]></given-names>
</name>
<name>
<surname><![CDATA[Hermes]]></surname>
<given-names><![CDATA[Elisangela]]></given-names>
</name>
<name>
<surname><![CDATA[Basto]]></surname>
<given-names><![CDATA[Paulo Roberto Haidamus de Oliveira]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotecnologia: progresso científico, material, global e ético]]></article-title>
<source><![CDATA[Persona y Bioética]]></source>
<year>2014</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>107-18</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gispert]]></surname>
<given-names><![CDATA[Ignasi]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Overview of nanomedicines regulation in the European Union]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Fuente]]></surname>
<given-names><![CDATA[Jesús M. de la]]></given-names>
</name>
<name>
<surname><![CDATA[Grazu]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<source><![CDATA[Frontiers of nanoscience]]></source>
<year>2012</year>
<volume>4</volume>
<page-range>487-507</page-range><publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Graur]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Elisei]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Szasz]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Neagos]]></surname>
<given-names><![CDATA[H. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Muresan]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Furcea]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Neagoe]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Braicu]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Katona]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Diudea]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethical issues in nanomedicine]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Vlad]]></surname>
<given-names><![CDATA[Simona]]></given-names>
</name>
<name>
<surname><![CDATA[Ciupa]]></surname>
<given-names><![CDATA[Radu V.]]></given-names>
</name>
</person-group>
<source><![CDATA[International Conference on Advancements of Medicine and Health Care through Technology]]></source>
<year>2011</year>
<page-range>9-12</page-range><publisher-loc><![CDATA[Berlín ]]></publisher-loc>
<publisher-name><![CDATA[Heidelberg: Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haker]]></surname>
<given-names><![CDATA[Hille]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicine and European Ethics - Part One]]></article-title>
<source><![CDATA[Ethics for Graduate Researchers]]></source>
<year>2013</year>
<page-range>87-99</page-range><publisher-loc><![CDATA[Oxford ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halappanavar]]></surname>
<given-names><![CDATA[Sabina]]></given-names>
</name>
<name>
<surname><![CDATA[Vogel]]></surname>
<given-names><![CDATA[Ulla]]></given-names>
</name>
<name>
<surname><![CDATA[Wallin]]></surname>
<given-names><![CDATA[Hakan]]></given-names>
</name>
<name>
<surname><![CDATA[Yauk]]></surname>
<given-names><![CDATA[Carole L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk]]></article-title>
<source><![CDATA[WIREs Nanomedicine and Nanobiotechnology]]></source>
<year>2018</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hogle]]></surname>
<given-names><![CDATA[Linda F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Concepts of risk in nanomedicine research]]></article-title>
<source><![CDATA[The Journal of Law, Medicine &amp; Ethics]]></source>
<year>2012</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>809-22</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Invernizzi]]></surname>
<given-names><![CDATA[Noela]]></given-names>
</name>
<name>
<surname><![CDATA[Foladori]]></surname>
<given-names><![CDATA[Guillermo]]></given-names>
</name>
<name>
<surname><![CDATA[Robles-Belmont]]></surname>
<given-names><![CDATA[Eduardo]]></given-names>
</name>
<name>
<surname><![CDATA[Záyago Lau]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
<name>
<surname><![CDATA[Arteaga Figueroa]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
<name>
<surname><![CDATA[Bagattolli]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<name>
<surname><![CDATA[Carrozza]]></surname>
<given-names><![CDATA[Tomás Javier]]></given-names>
</name>
<name>
<surname><![CDATA[Chiancone]]></surname>
<given-names><![CDATA[Adriana]]></given-names>
</name>
<name>
<surname><![CDATA[Urquijo]]></surname>
<given-names><![CDATA[William]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotechnology for social needs: contributions from latin american research in the areas of health, energy and water]]></article-title>
<source><![CDATA[Journal of Nanoparticle Research]]></source>
<year>2015</year>
<volume>17</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>233</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[Kewal K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Introduction]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Kewal K.]]></surname>
<given-names><![CDATA[Jain]]></given-names>
</name>
</person-group>
<source><![CDATA[The Handbook of Nanomedicine]]></source>
<year>2017</year>
<page-range>1-9</page-range><publisher-loc><![CDATA[Nueva York, NY ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khare]]></surname>
<given-names><![CDATA[Vaibhav]]></given-names>
</name>
<name>
<surname><![CDATA[Saxena]]></surname>
<given-names><![CDATA[Ajit K.]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[Prem N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 15 - Toxicology considerations in nanomedicine]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[Sabu]]></given-names>
</name>
<name>
<surname><![CDATA[Grohens]]></surname>
<given-names><![CDATA[Yves]]></given-names>
</name>
<name>
<surname><![CDATA[Ninan]]></surname>
<given-names><![CDATA[Neethu]]></given-names>
</name>
</person-group>
<source><![CDATA[Nanotechnology applications for tissue engineering]]></source>
<year>2015</year>
<page-range>239-61</page-range><publisher-loc><![CDATA[Oxford ]]></publisher-loc>
<publisher-name><![CDATA[William Andrew Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khushf]]></surname>
<given-names><![CDATA[George]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Upstream ethics in nanomedicine: a call for research]]></article-title>
<source><![CDATA[Nanomedicine]]></source>
<year>2007</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>511-21</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[Jiyoung]]></given-names>
</name>
<name>
<surname><![CDATA[Jo]]></surname>
<given-names><![CDATA[Young-um]]></given-names>
</name>
<name>
<surname><![CDATA[Na]]></surname>
<given-names><![CDATA[Kun]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Photodynamic therapy with smart nanomedicine]]></article-title>
<source><![CDATA[Archives of Pharmacal Research]]></source>
<year>2020</year>
<volume>43</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-31</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kimmelman]]></surname>
<given-names><![CDATA[Jonathan]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Beyond human subjects: risk, ethics, and clinical development of nanomedicines]]></article-title>
<source><![CDATA[The Journal of Law, Medicine &amp; Ethics]]></source>
<year>2012</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>841-7</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lemine]]></surname>
<given-names><![CDATA[O. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 7 - Magnetic hyperthermia therapy using hybrid magnetic nanostructures]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Bohara]]></surname>
<given-names><![CDATA[Raghvendra Ashok]]></given-names>
</name>
<name>
<surname><![CDATA[Thorat]]></surname>
<given-names><![CDATA[Nanasaheb]]></given-names>
</name>
</person-group>
<source><![CDATA[Hybrid nanostructures for cancer theranostics]]></source>
<year>2019</year>
<page-range>125-38</page-range><publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Xue]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Xue-Ning]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Xiao-Dong]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[Jin]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multimodality imaging in nanomedicine and nanotheranostics]]></article-title>
<source><![CDATA[Cancer Biology &amp; Medicine]]></source>
<year>2016</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>339-48</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lima-Dora]]></surname>
<given-names><![CDATA[Cristiana]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira-Primo]]></surname>
<given-names><![CDATA[Fabian]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[Gabriela de-Moraes-Soares]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reflexões bioéticas acerca da inovação em nanomedicamentos]]></article-title>
<source><![CDATA[Revista de Bioética y Derecho]]></source>
<year>2019</year>
<volume>45</volume>
<page-range>197-212</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Goerne]]></surname>
<given-names><![CDATA[Tessy María]]></given-names>
</name>
<name>
<surname><![CDATA[Bolio]]></surname>
<given-names><![CDATA[Antonio Paoli]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ética para nanomedicina: primera propuesta para la elaboración de un código]]></article-title>
<source><![CDATA[Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología]]></source>
<year>2009</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahapatra]]></surname>
<given-names><![CDATA[Indrani]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[Julian R. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Dobson]]></surname>
<given-names><![CDATA[Peter J.]]></given-names>
</name>
<name>
<surname><![CDATA[Owen]]></surname>
<given-names><![CDATA[Richard]]></given-names>
</name>
<name>
<surname><![CDATA[Lynch]]></surname>
<given-names><![CDATA[Iseult]]></given-names>
</name>
<name>
<surname><![CDATA[Lead]]></surname>
<given-names><![CDATA[Jamie R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expert perspectives on potential environmental risks from nanomedicines and adequacy of the current guideline on environmental risk assessment]]></article-title>
<source><![CDATA[Environmental Science: Nano]]></source>
<year>2018</year>
<volume>5</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1873-89</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marchant]]></surname>
<given-names><![CDATA[Gary E.]]></given-names>
</name>
<name>
<surname><![CDATA[Sylvester]]></surname>
<given-names><![CDATA[Douglas J.]]></given-names>
</name>
<name>
<surname><![CDATA[Abbott]]></surname>
<given-names><![CDATA[Kenneth W.]]></given-names>
</name>
<name>
<surname><![CDATA[Danforth]]></surname>
<given-names><![CDATA[Tara Lynn]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International harmonization of regulation of nanomedicine]]></article-title>
<source><![CDATA[Studies in Ethics, Law, and Technology]]></source>
<year>2010</year>
<volume>3</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meel]]></surname>
<given-names><![CDATA[Roy van der]]></given-names>
</name>
<name>
<surname><![CDATA[Sulheim]]></surname>
<given-names><![CDATA[Einar]]></given-names>
</name>
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[Yang]]></given-names>
</name>
<name>
<surname><![CDATA[Kiessling]]></surname>
<given-names><![CDATA[Fabian]]></given-names>
</name>
<name>
<surname><![CDATA[Mulder]]></surname>
<given-names><![CDATA[Willem J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lammers]]></surname>
<given-names><![CDATA[Twan]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Smart cancer nanomedicine]]></article-title>
<source><![CDATA[Nature Nanotechnology]]></source>
<year>2019</year>
<volume>14</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1007-17</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nerlich]]></surname>
<given-names><![CDATA[Brigitte]]></given-names>
</name>
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[David D.]]></given-names>
</name>
<name>
<surname><![CDATA[Ulph]]></surname>
<given-names><![CDATA[Fiona]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risks and benefits of nanotechnology: How young adults perceive possible advances in nanomedicine compared with conventional treatments]]></article-title>
<source><![CDATA[Health, Risk &amp; Society]]></source>
<year>2007</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>159-71</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="book">
<collab>NNI</collab>
<source><![CDATA[What it is and how it works]]></source>
<year></year>
<publisher-name><![CDATA[National Nanotechnology Initiative]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ocampo]]></surname>
<given-names><![CDATA[José Antonio]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La gobernanza económica y social en el sistema de las Naciones Unidas]]></article-title>
<source><![CDATA[Gobernanza global y desarrollo: Nuevos desafíos y prioridades de la cooperación internacional]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Siglo Veintiuno]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="">
<collab>Organización para la Cooperación y el Desarrollo Económicos</collab>
<source><![CDATA[Technology governance. Technology governance]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="">
<collab>OCDE</collab>
<collab>Allianz</collab>
<source><![CDATA[Opportunities and risks of nanotechnologies]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pierre]]></surname>
<given-names><![CDATA[Jon]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[B. Guy]]></given-names>
</name>
</person-group>
<source><![CDATA[Governance, politics, and the State]]></source>
<year>2000</year>
<publisher-loc><![CDATA[Nueva York ]]></publisher-loc>
<publisher-name><![CDATA[St. Martin&#8217;s Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qiu]]></surname>
<given-names><![CDATA[Guangyu]]></given-names>
</name>
<name>
<surname><![CDATA[Gai]]></surname>
<given-names><![CDATA[Zhibo]]></given-names>
</name>
<name>
<surname><![CDATA[Tao]]></surname>
<given-names><![CDATA[Yile]]></given-names>
</name>
<name>
<surname><![CDATA[Schmitt]]></surname>
<given-names><![CDATA[Jean]]></given-names>
</name>
<name>
<surname><![CDATA[Kullak-Ublick]]></surname>
<given-names><![CDATA[Gerd A.]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Jing]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection]]></article-title>
<source><![CDATA[ACS Nano]]></source>
<year>2020</year>
<volume>14</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>5268-77</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rahim]]></surname>
<given-names><![CDATA[Mia M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicine regulation in Australia]]></article-title>
<source><![CDATA[Alternative Law Journal]]></source>
<year>2019</year>
<volume>44</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>133-7</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rana]]></surname>
<given-names><![CDATA[Vikas]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[Radhika]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 5 - Recent advances in development of nano drug delivery]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Mohapatra]]></surname>
<given-names><![CDATA[Shyam S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ranjan]]></surname>
<given-names><![CDATA[Shivendu]]></given-names>
</name>
<name>
<surname><![CDATA[Dasgupta]]></surname>
<given-names><![CDATA[Nandita]]></given-names>
</name>
<name>
<surname><![CDATA[Mishra]]></surname>
<given-names><![CDATA[Raghvendra Kumar]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[Sabu]]></given-names>
</name>
</person-group>
<source><![CDATA[Applications of targeted nano drugs and delivery systems]]></source>
<year>2019</year>
<page-range>93-131</page-range><publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reilly]]></surname>
<given-names><![CDATA[Raymond M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carbon nanotubes: potential benefits and risks of nanotechnology in nuclear medicine]]></article-title>
<source><![CDATA[Journal of Nuclear Medicine]]></source>
<year>2007</year>
<volume>48</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1039-42</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Renn]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Roco]]></surname>
<given-names><![CDATA[M. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotechnology and the need for risk governance]]></article-title>
<source><![CDATA[Journal of Nanoparticle Research]]></source>
<year>2006</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>153-91</page-range></nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Resnik]]></surname>
<given-names><![CDATA[David B.]]></given-names>
</name>
<name>
<surname><![CDATA[Tinkle]]></surname>
<given-names><![CDATA[Sally S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethics in nanomedicine]]></article-title>
<source><![CDATA[Nanomedicine]]></source>
<year>2007</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>345-50</page-range></nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rycroft]]></surname>
<given-names><![CDATA[Taylor]]></given-names>
</name>
<name>
<surname><![CDATA[Trump]]></surname>
<given-names><![CDATA[Benjamin]]></given-names>
</name>
<name>
<surname><![CDATA[Poinsatte-Jones]]></surname>
<given-names><![CDATA[Kelsey]]></given-names>
</name>
<name>
<surname><![CDATA[Linkov]]></surname>
<given-names><![CDATA[Igor]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotoxicology and nanomedicine: making development decisions in an evolving governance environment]]></article-title>
<source><![CDATA[Journal of Nanoparticle Research]]></source>
<year>2018</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>52</page-range></nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saldivar-Tanaka]]></surname>
<given-names><![CDATA[Laura]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Regulando la nanotecnología]]></article-title>
<source><![CDATA[Mundo Nano. Revista Interdisciplinaria en Nanociencias y Nanotecnología]]></source>
<year>2019</year>
<volume>12</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>37-57</page-range></nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandler]]></surname>
<given-names><![CDATA[Ronald]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicine and nanomedical ethics]]></article-title>
<source><![CDATA[The American Journal of Bioethics: AJOB]]></source>
<year>2009</year>
<volume>9</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>16-7</page-range></nlm-citation>
</ref>
<ref id="B65">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sassen]]></surname>
<given-names><![CDATA[Saskia]]></given-names>
</name>
</person-group>
<source><![CDATA[Territorio, autoridad y derechos: De los ensamblajes medievales a los ensamblajes globales]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Katz Editores]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B66">
<nlm-citation citation-type="book">
<collab>SCENIHR</collab>
<source><![CDATA[Guidance on the determination of potential health effects of nanomaterials used in medical devices]]></source>
<year>2015</year>
<publisher-name><![CDATA[Publications Office of the European Union]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B67">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shvedova]]></surname>
<given-names><![CDATA[Anna]]></given-names>
</name>
<name>
<surname><![CDATA[Pietroiusti]]></surname>
<given-names><![CDATA[Antonio]]></given-names>
</name>
<name>
<surname><![CDATA[Kagan]]></surname>
<given-names><![CDATA[Valerian]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanotoxicology ten years later: lights and shadows]]></article-title>
<source><![CDATA[Toxicology and Applied Pharmacology]]></source>
<year>2016</year>
<volume>299</volume>
<page-range>1-2</page-range></nlm-citation>
</ref>
<ref id="B68">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smolkova]]></surname>
<given-names><![CDATA[Bozena]]></given-names>
</name>
<name>
<surname><![CDATA[Dusinska]]></surname>
<given-names><![CDATA[Maria]]></given-names>
</name>
<name>
<surname><![CDATA[Gabelova]]></surname>
<given-names><![CDATA[Alena]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicine and epigenome. Possible health risks]]></article-title>
<source><![CDATA[Food and Chemical Toxicology]]></source>
<year>2017</year>
<volume>109</volume>
<page-range>780-96</page-range></nlm-citation>
</ref>
<ref id="B69">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sportelli]]></surname>
<given-names><![CDATA[Maria Chiara]]></given-names>
</name>
<name>
<surname><![CDATA[Izzi]]></surname>
<given-names><![CDATA[Margherita]]></given-names>
</name>
<name>
<surname><![CDATA[Kukushkina]]></surname>
<given-names><![CDATA[Ekaterina A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hossain]]></surname>
<given-names><![CDATA[Syed Imdadul]]></given-names>
</name>
<name>
<surname><![CDATA[Picca]]></surname>
<given-names><![CDATA[Rosaria Anna]]></given-names>
</name>
<name>
<surname><![CDATA[Ditaranto]]></surname>
<given-names><![CDATA[Nicoletta]]></given-names>
</name>
<name>
<surname><![CDATA[Cioffi]]></surname>
<given-names><![CDATA[Nicola]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Can nanotechnology and materials science help the fight against SARS-CoV-2?]]></article-title>
<source><![CDATA[Nanomaterials (Basel, Switzerland)]]></source>
<year>2020</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B70">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Szelenyi]]></surname>
<given-names><![CDATA[Istvan]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases]]></article-title>
<source><![CDATA[Inflammation Research]]></source>
<year>2012</year>
<volume>61</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B71">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tyshenko]]></surname>
<given-names><![CDATA[Michael G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical nanotechnology using genetic material and the need for precaution in design and risk assessments]]></article-title>
<source><![CDATA[International Journal of Nanotechnology]]></source>
<year>2008</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>116-23</page-range></nlm-citation>
</ref>
<ref id="B72">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vidal Correa]]></surname>
<given-names><![CDATA[Laura Elena]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis comparativo de la regulación en nanotecnología en Estados Unidos y en la Unión Europea]]></article-title>
<source><![CDATA[Boletín mexicano de derecho comparado]]></source>
<year>2016</year>
<volume>49</volume>
<numero>147</numero>
<issue>147</issue>
<page-range>277-301</page-range></nlm-citation>
</ref>
<ref id="B73">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vivekanandan]]></surname>
<given-names><![CDATA[Jayashree]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nano applications, mega challenges: the case of the health sector in India]]></article-title>
<source><![CDATA[Studies in Ethics, Law, and Technology]]></source>
<year>2009</year>
<volume>3</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B74">
<nlm-citation citation-type="">
<collab>WHO</collab>
<source><![CDATA[Nanotechnology and human health: Scientific evidence and risk governance]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Bonn, Germany ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B75">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wolf]]></surname>
<given-names><![CDATA[Susan M.]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[Cortney M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Designing oversight for nanomedicine research in human subjects: systematic analysis of exceptional oversight for emerging technologies]]></article-title>
<source><![CDATA[Journal of Nanoparticle Research]]></source>
<year>2011</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1449-65</page-range></nlm-citation>
</ref>
<ref id="B76">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[Lin-Ping]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Danyang]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Zibiao]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Grand challenges in nanomedicine]]></article-title>
<source><![CDATA[Materials Science and Engineering: C]]></source>
<year>2020</year>
<volume>106</volume>
<page-range>110302</page-range></nlm-citation>
</ref>
<ref id="B77">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Chenyang]]></given-names>
</name>
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[Liang]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Xin]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[Shuang]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Chunying]]></given-names>
</name>
<name>
<surname><![CDATA[Gu]]></surname>
<given-names><![CDATA[Zhanjun]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Yuliang]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Progress, challenges, and future of nanomedicine]]></article-title>
<source><![CDATA[Nano Today]]></source>
<year>2020</year>
<volume>35</volume>
<page-range>101008</page-range></nlm-citation>
</ref>
<ref id="B78">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[Junwen]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Weishu]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A tale of two databases: the use of Web of Science and Scopus in academic papers]]></article-title>
<source><![CDATA[Scientometrics]]></source>
<year>2020</year>
<volume>123</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>321-35</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
